Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 422 of 1,261
  1. US 10662215

    Cyclic peroxides as prodrugs for selective delivery of agents

    The Regents of the University of California · Granted May 26, 2020 · Expires May 21, 2040

    granted
  2. US 10662160

    Crystalline salts of a plasma kallikrein inhibitor

    BioCryst Pharmaceuticals, Inc. · Granted May 26, 2020 · Expires May 21, 2040

    granted
  3. US 10660918

    Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell

    China Medical University · Granted May 26, 2020 · Expires May 21, 2040

    granted
  4. US 2020155578

    Pharmaceutical Formulations for Subcutaneous Administration

    ABBVIE INC [US] · Granted May 21, 2020 · Expires May 16, 2040

    granted
  5. US 10653789

    Polymer-drug conjugates for combination anticancer therapy

    The Regents of the University of California · Granted May 19, 2020 · Expires May 14, 2040

    granted
  6. US 10653710

    Combination therapy for treating malignancies

    Agios Pharmaceuticals, Inc. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  7. US 10653665

    Method of treatment

    VANDA PHARMACEUTICALS INC. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  8. US 10653172

    Natural stilbenes as sweeteners or sweetener enhancer

    Analyticon Discovery GmbH · Granted May 19, 2020 · Expires May 14, 2040

    granted
  9. US 10653689

    Combination-based treatment method

    Nektar Therapeutics · Granted May 19, 2020 · Expires May 14, 2040

    granted
  10. US 10655109

    Recombinant respiratory syncytial virus stains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 19, 2020 · Expires May 14, 2040

    granted
  11. US 10653723

    Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  12. US 10655183

    Carcinoma diagnosis and treatment based on ODC1 genotype

    Arizona Board of Regents on Behalf of the University of Arizona · Granted May 19, 2020 · Expires May 14, 2040

    granted
  13. US 10654898

    Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 19, 2020 · Expires May 14, 2040

    granted
  14. US 10654864

    Modified cytotoxins and their therapeutic use

    The Regents of the University of California · Granted May 19, 2020 · Expires May 14, 2040

    granted
  15. US 10654802

    Indoline derivatives and method for using and producing the same

    Arizona Board of Regents on Behalf of the University · Granted May 19, 2020 · Expires May 14, 2040

    granted
  16. US 10653704

    Inhalable formulation

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  17. US 10655129

    Compositions and their uses directed to huntingtin

    Ionis Pharmaceuticals, Inc. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  18. US 10654850

    Pyridazinones and methods of use thereof

    Goldfinch Bio, Inc. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  19. US 10653169

    Food thickening agent, method for producing food thickening agent

    Kent Precision Foods Group, Inc. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  20. US 10654916

    Compositions and methods for the treatment of neuromyelitis optica

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted May 19, 2020 · Expires May 14, 2040

    granted
  21. US 10655103

    Equine progenitor cells

    University College Cardiff Consultants Limited · Granted May 19, 2020 · Expires May 14, 2040

    granted
  22. US 10654874

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 19, 2020 · Expires May 14, 2040

    granted
  23. US 10654834

    Non-systemic TGR5 agonists

    VENENUM BIODESIGN, LLC · Granted May 19, 2020 · Expires May 14, 2040

    granted
  24. US 10653150

    Shelf life and color profile of resin compositions with silver nanoparticles

    The Board of Regents of the University of Texas System · Granted May 19, 2020 · Expires May 14, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.